Disc Medicine, Inc.
IRON
$38.73
$3.509.94%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 33.05M | 30.45M | 26.81M | 24.67M | 21.86M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 129.72M | 124.88M | 110.99M | 97.46M | 91.13M |
Operating Income | -129.72M | -124.88M | -110.99M | -97.46M | -91.13M |
Income Before Tax | -109.00M | -103.27M | -90.89M | -80.52M | -76.33M |
Income Tax Expenses | 355.00K | 211.00K | 117.00K | 81.00K | 99.00K |
Earnings from Continuing Operations | -109.36 | -103.48 | -91.00 | -80.60 | -76.43 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -109.36M | -103.48M | -91.00M | -80.60M | -76.43M |
EBIT | -129.72M | -124.88M | -110.99M | -97.46M | -91.13M |
EBITDA | -129.56M | -124.71M | -110.80M | -97.36M | -91.03M |
EPS Basic | -3.98 | -3.97 | -3.66 | -3.37 | -3.49 |
Normalized Basic EPS | -2.48 | -2.51 | -2.32 | -2.10 | -2.17 |
EPS Diluted | -3.98 | -3.97 | -3.66 | -3.37 | -3.49 |
Normalized Diluted EPS | -2.48 | -2.51 | -2.32 | -2.10 | -2.17 |
Average Basic Shares Outstanding | 110.39M | 104.84M | 99.22M | 95.06M | 89.20M |
Average Diluted Shares Outstanding | 110.39M | 104.84M | 99.22M | 95.06M | 89.20M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |